© 2021 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
2 Clarke DriveSuite 100Cranbury, NJ 08512
© 2021 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
October 12th 2021
November 10th 2021
Rodolfo Bordoni, MD, discusses the utility of adjuvant osimertinib in lung cancer.
John F. Lazar, MD, discusses risk stratification for chemotherapy and adjuvant therapy in lung cancer.
Corey J. Langer, MD, discusses the need for reflex testing in patients with non–small cell lung cancer.